Letaplimab

• Target:

  Others

• Related Pathways:

  Others

• Purity:

  0.974

• Bioactivity:

  Letaplimab (IBI-188) is a humanized IgG4 class antibody targeting CD47 and is often used in combination with azacitidine for the treatment of primary diagnosis of intermediate- to high-risk myelodysplastic syndromes.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2283356-07-8